AFIB
Acutus Medical, Inc.
OTC Markets OTCPKUSDEQUITY
Healthcare
DELAYED
Sell
-42/100
Last price
0.00
■ 0.00 (0.00%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Overlay another symbol
Both series are rebased to 0% at the left edge, so the lines show relative performance rather than price.
Tool
1D
—
H —
L —
Range —
Vol —
vs
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
—
Prev close
0.00
Day high
0.00
Day low
0.00
Volume
10.00K
Market cap
$2.99K
P/E (TTM)
—
52W range
0.00 – 0.01
Trailing performance
Returnvs SPY
1W
0.00%
-1.9%
1M
0.00%
-1.2%
3M
0.00%
-4.5%
6M
0.00%
-18.2%
YTD
-50.00%
-64.2%
1Y
-80.00%
-96.4%
3Y
-99.99%
-182.2%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Free account
11 more panels on AFIB open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Insider net activity
Net shares
0
Net selling
Buy transactions
0
0 shares
Sell transactions
0
—
Net transactions
0
Buys less sells
Sell : buy shares
—
Not enough filings
Insider-held shares
403.22K
Total on file
Fundamentals
Market cap$2.99K
Enterprise value$21.75M
Revenue (TTM)$20.16M
Gross profit$1.01M
EBITDA$-9.13M
Net income$-4.54M
EPS (TTM)$-0.15
Free cash flow$-6.78M
Total cash$14.02M
Total debt$35.76M
Book value / share$-0.39
Shares outstanding29.91M
Float24.78M
Short % of float0.94%
Dividend yield0.00%
Beta (5Y)5.77
Valuation & profitability ratios
Trailing P/E—
Forward P/E-0.00
PEG ratio—
Price / sales—
Price / book—
EV / revenue1.08
EV / EBITDA-2.38
Gross margin5.03%
Operating margin-21.75%
Profit margin-47.36%
Return on equity—
Return on assets-14.26%
Debt / equity—
Current ratio2.06
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2024 | 2023 | 2022 | 2021 | YoY |
|---|---|---|---|---|---|
| Total revenue | $20.16M | $7.16M | $3.03M | $17.26M | +181.4% |
| Operating revenue | $20.16M | $7.16M | $3.03M | $17.26M | +181.4% |
| Cost of revenue | $19.14M | $10.30M | $4.94M | $32.92M | +85.8% |
| Gross profit | $1.01M | -$3.14M | -$1.91M | -$15.66M | +132.3% |
| Research & development | $0 | $3.48M | $3.12M | $36.68M | -100.0% |
| Selling, general & admin | $10.44M | $14.07M | $20.32M | $63.52M | -25.8% |
| Total operating expense | $10.44M | $17.55M | $23.43M | $100.21M | -40.5% |
| Operating income | -$9.42M | -$20.68M | -$25.34M | -$115.87M | +54.4% |
| Net interest income | -$5.00M | -$3.07M | -$4.28M | -$5.56M | -62.9% |
| Pre-tax income | -$4.54M | -$11.86M | $28.85M | -$117.68M | +61.7% |
| Tax provision | $0 | $63.00K | $15.00K | $0 | -100.0% |
| Net income | -$9.55M | -$81.66M | -$39.62M | -$117.68M | +88.3% |
| Net income to common | -$9.55M | -$81.66M | -$39.62M | -$117.68M | +88.3% |
| Basic EPS | — | -2.81 | -1.40 | -4.11 | — |
| Diluted EPS | — | -2.81 | -1.40 | -4.11 | — |
| EBIT | $1.22M | -$6.20M | $34.00M | -$112.01M | +119.7% |
| EBITDA | $2.25M | -$5.33M | $35.20M | -$105.12M | +142.2% |
| Basic shares | — | 29.10M | 28.32M | 28.65M | — |
| Diluted shares | — | 29.10M | 28.32M | 28.65M | — |
| Line item | 2024 | 2023 | 2022 | 2021 | YoY |
|---|---|---|---|---|---|
| Cash & equivalents | $14.02M | $19.17M | $25.58M | $24.07M | -26.9% |
| Cash & short-term investments | $14.02M | $22.40M | $70.45M | $100.77M | -37.4% |
| Accounts receivable | $7.88M | $11.35M | $17.92M | $3.63M | -30.6% |
| Inventory | $1.79M | $4.28M | $1.79M | $16.41M | -58.2% |
| Total current assets | $25.58M | $46.25M | $117.87M | $126.29M | -44.7% |
| Property, plant & equipment | $2.98M | $4.01M | $5.54M | $18.19M | -25.9% |
| Goodwill & intangibles | — | — | $1.58M | $17.04M | — |
| Total assets | $28.65M | $53.96M | $133.44M | $169.79M | -46.9% |
| Total current liabilities | $12.44M | $18.94M | $19.87M | $18.51M | -34.3% |
| Current debt | $7.00M | $1.86M | — | — | +275.8% |
| Long-term debt | $25.56M | $32.65M | $34.43M | $40.41M | -21.7% |
| Total debt | $35.76M | $38.48M | $38.86M | $45.40M | -7.1% |
| Total liabilities | $40.24M | $54.84M | $58.42M | $64.07M | -26.6% |
| Retained earnings | -$609.52M | -$599.98M | -$518.31M | -$478.70M | -1.6% |
| Shareholder equity | -$11.59M | -$879.00K | $75.02M | $105.73M | -1,218.8% |
| Working capital | $13.14M | $27.31M | $98.00M | $107.78M | -51.9% |
| Net tangible assets | -$11.59M | -$879.00K | $75.02M | $88.69M | -1,218.8% |
| Shares issued | 29.91M | 29.31M | 28.55M | 27.96M | +2.0% |
| Line item | 2024 | 2023 | 2022 | 2021 | YoY |
|---|---|---|---|---|---|
| Net income | -$4.54M | -$11.92M | -$39.62M | -$117.68M | +61.9% |
| Depreciation & amortisation | $1.03M | $874.00K | $1.21M | $6.89M | +17.5% |
| Stock-based compensation | $459.00K | $3.03M | $3.40M | $13.75M | -84.9% |
| Change in working capital | -$4.01M | $916.00K | -$2.61M | -$3.79M | -537.7% |
| Operating cash flow | -$31.66M | -$63.12M | -$88.92M | -$99.68M | +49.8% |
| Capital expenditure | -$112.00K | -$219.00K | -$228.00K | -$9.97M | +48.9% |
| Investing cash flow | $22.15M | $58.55M | $104.75M | $19.07M | -62.2% |
| Share buybacks | — | $0 | -$111.00K | $0 | — |
| Financing cash flow | -$2.89M | -$2.66M | -$11.62M | $79.57M | -8.5% |
| Free cash flow | -$31.77M | -$63.34M | -$89.14M | -$109.66M | +49.8% |
| End cash position | $14.02M | $26.20M | $31.35M | $24.22M | -46.5% |
Options analytics
Put / call volume
—
—
Put / call open interest
—
Positioning, not flow
Max pain
—
—
ATM implied vol
—
Nearest strike to spot
Skew (10% OTM)
—
—
Call volume
0
Contracts, this expiry
Put volume
0
Contracts, this expiry
Heaviest call OI
—
—
Heaviest put OI
—
—
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Earnings
Reported vs expected · EPS
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Sep 2023 | -0.56 | -0.52 | +6.3% |
| Jun 2023 | -0.62 | -0.60 | +3.2% |
| Mar 2023 | -0.64 | -0.59 | +7.8% |
| Dec 2022 | -0.61 | -0.63 | -3.3% |
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | — | — | $0 | — |
| Next quarter | — | — | $0 | — |
| Current year | — | — | $0 | — |
| Next year | — | — | $0 | — |
Analyst targets & ownership
Mean target—
High target—
Low target—
Implied upside—
Analyst count—
ConsensusNONE
Strong buy / Buy— / —
Hold—
Sell / Strong sell— / —
Held by insiders1.35%
Held by institutions8.85%
Institutions holding1
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
0.00
+0.00% from price
SMA 20
0.00
0.00% from price
SMA 50
0.00
-1.96% from price
SMA 100
0.00
-10.71% from price
SMA 200
0.00
-48.72% from price
EMA 12
0.00
-0.03% from price
EMA 26
0.00
-0.57% from price
EMA 50
0.00
-4.63% from price
RSI (14)
47.4
Neutral
MACD (12,26,9)
-0.00
Hist 0.00
ATR (14)
0.00
—
Realised vol 30D
0.0%
Annualised
Bollinger upper
0.00
20, 2σ
Bollinger lower
0.00
20, 2σ
50 / 200 cross
Death
0.00 vs 0.00
Trend bias
Below 200
-48.72%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
-0.53
Less volatile than market
Correlation to SPY
-0.00
Largely independent
Realised vol 30D
0.0%
Annualised
Market vol 1Y
13.0%
SPY, annualised
Max drawdown 1Y
-97.4%
Peak to trough
Max drawdown 5Y
-100.0%
Peak to trough
ATR 14
0.00
Average true range
Beta (reported)
5.77
5Y monthly, from filing
Short interest
Shares short
272.59K
Prior 845.17K
Change vs prior
-67.7%
Shorts covering
% of float
0.94%
Normal
% of shares out
0.92%
Against total outstanding
Days to cover
0.8
Liquid
Float
24.78M
Freely tradeable shares
Exchanges publish short interest twice a month with a settlement lag, so this is roughly two weeks behind. Days to cover divides shares short by average daily volume — it estimates how long covering would take, not whether it will happen.
Rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Aug 16, 22 | Goldman Sachs | MAINTAINED | — | Neutral |
| Jun 24, 22 | BTIG | MAINTAINED | — | Buy |
| Apr 27, 22 | BTIG | UPGRADE | Neutral | Buy |
| Apr 14, 22 | Goldman Sachs | MAINTAINED | — | Neutral |
| Jan 20, 22 | BTIG | DOWNGRADE | Buy | Neutral |
| Jan 14, 22 | Canaccord Genuity | DOWNGRADE | Buy | Hold |
| Nov 12, 21 | JP Morgan | DOWNGRADE | Neutral | Underweight |
| Nov 12, 21 | Canaccord Genuity | MAINTAINED | — | Buy |
| Oct 22, 21 | Goldman Sachs | INITIATED | — | Neutral |
| Jul 15, 21 | Canaccord Genuity | UPGRADE | Hold | Buy |
| Mar 19, 21 | Canaccord Genuity | MAINTAINED | — | Hold |
| Mar 19, 21 | William Blair | DOWNGRADE | Outperform | Market Perform |
Dividends & splits
Forward rate—
Forward yield0.00%
5-year avg yield—
Payout ratio0.00%
Ex-dividend date—
Next pay date—
Last split—
Split date—
SEC filings
Periodic Financial Reports
10-K · 2025-03-24
Notice of suspension of duty to file reports pursuant to Section 13 and 15(d) of the Act
15-15D · 2025-01-24
Offering Registrations
S-8 POS · 2025-01-21
Corporate Changes & Voting Matters
8-K · 2024-12-04
Corporate Changes & Voting Matters
8-K · 2024-11-15
Corporate Changes & Voting Matters
8-K · 2024-11-14
Corporate Changes & Voting Matters
8-K · 2024-10-17
Corporate Changes & Voting Matters
8-K · 2024-08-08
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.